opioid dependence phenotype
Evidence from:
primary |
all sources
Related entities (148)
Mentioned in (64)
Papers in which this entity is mentioned.
- Mapping the genetic landscape across 14 psychiatric disorders. (2026)
- Alcohol use disorder is associated with altered frontomedial phase-amplitude coupling strength during resting state. (2026)
- Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. (2024)
- Punitive legal responses to prenatal drug use in the United States: A survey of state policies and systematic review of their public health impacts. (2024)
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- Physician Reluctance to Intervene in Addiction: A Systematic Review. (2024)
- Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality. (2021)
- Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
- Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. (2021)
- Genetics of substance use disorders in the era of big data. (2021)
- Genome-wide association analysis of opioid use disorder: A novel approach using clinical data. (2020)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- Genome-wide association study identifies a novel locus for cannabis dependence. (2018)
- Intersection of stress and gender in association with transitions in past year DSM-5 substance use disorder diagnoses in the United States. (2018)
- Human Genetics of Addiction: New Insights and Future Directions. (2018)
- Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity. (2017)
- Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
- KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. (2016)
- Polygenic risk for alcohol dependence associates with alcohol consumption, cognitive function and social deprivation in a population-based cohort. (2016)
- Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. (2015)
- Dissecting ancestry genomic background in substance dependence genome-wide association studies. (2015)
- Genomewide Association Study for Maximum Number of Alcoholic Drinks in European Americans and African Americans. (2015)
- Genome-wide association study of nicotine dependence in American populations: identification of novel risk loci in both African-Americans and European-Americans. (2015)
- The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. (2014)
- Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. (2014)
- Pharmacogenetics of OPRM1. (2014)
- Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample. (2013)
- Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. (2013)
- ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. (2013)
- Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder. (2013)
- Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. (2012)
- Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. (2012)
- The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
- The genetics of the opioid system and specific drug addictions. (2012)
- Association of CHRNA4 polymorphisms with smoking behavior in two populations. (2011)
- Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. (2011)
- TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. (2011)
- Opioid dependence latent structure: two classes with differing severity? (2011)
- Haplotype block structure of the genomic region of the mu opioid receptor gene. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. (2011)
- Genome-wide scan for self-rating of the effects of alcohol in American Indians. (2010)
- Genome wide association for addiction: replicated results and comparisons of two analytic approaches. (2010)
- Obesity, smoking, and frontal brain dysfunction. (2010)
- Consilient research approaches in studying gene x environment interactions in alcohol research. (2010)
- Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. (2010)
- Expansion of the human mu-opioid receptor gene architecture: novel functional variants. (2009)
- Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. (2009)
- Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. (2009)
- From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. (2009)
- Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10. (2009)
- Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. (2009)
- New insights into the genetics of addiction. (2009)
- Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. (2009)
- Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. (2009)
- Protein kinases and addiction. (2008)
- Ethanol's molecular targets. (2008)
- EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
- Short scales to assess cannabis-related problems: a review of psychometric properties. (2008)
- Clock genes running amok. Clock genes and their role in drug addiction and depression. (2007)
- The role of stress in alcohol use, alcoholism treatment, and relapse. (1999)
Merged raw entities (22)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| opioid dependence | phenotype | 39 | 139 |
| opioid use disorder | phenotype | 18 | 63 |
| opioid addiction | phenotype | 11 | 40 |
| opiate dependence | phenotype | 10 | 13 |
| opioid abuse | phenotype | 5 | 10 |
| opioid analgesic dependence | phenotype | 2 | 2 |
| opioid-dependent | phenotype | 2 | 3 |
| opioid use disorders | phenotype | 2 | 2 |
| long-term opioid dependence | phenotype | 1 | 1 |
| opioid analgesic dependent | phenotype | 1 | 1 |
| opioid dependent | phenotype | 1 | 2 |
| addiction to opioids | phenotype | — | — |
| addictive properties of drugs | phenotype | — | — |
| dsm‑iv od | phenotype | — | — |
| opiate | phenotype | — | — |
| opiate dependent subjects | phenotype | — | — |
| opioid-addicted subjects | phenotype | — | — |
| opioid dependence liability | phenotype | — | — |
| opioid-dependent individuals | phenotype | — | — |
| opioids | phenotype | — | — |
| opioid use disorder (oud) | phenotype | — | — |
| oud patients | phenotype | — | — |